Recommended Guidelines for Screening for Underlying Malignancy in Extramammary Paget's Disease Based on Anatomic Subtype
Kibbi N, Owen J, Worley B, Alam M, Group E, Wang J, Harikumar V, Downing M, Aasi S, Aung P, Barker C, Bolotin D, Bordeaux J, Cartee T, Chandra S, Cho N, Choi J, Chung K, Cliby W, Dorigo O, Eisen D, Fujisawa Y, Golda N, Halfdanarson T, Iavazzo C, Jiang S, John E, Kanitakis J, Keimig E, Khan A, Linos E, Kim J, Kuzel T, Lawrence N, Leitao M, MacLean A, Maher I, Mittal B, Nehal K, Ozog D, Pettaway C, Rajan N, Ross J, Rossi A, Servaes S, Solomon M, Thomas V, Tolia M, Voelzke B, Waldman A, Wong M, Zhou Y, Brackett A, Poon E, Ahmed A. Recommended Guidelines for Screening for Underlying Malignancy in Extramammary Paget's Disease Based on Anatomic Subtype. Journal Of The American Academy Of Dermatology 2024 PMID: 39401611, DOI: 10.1016/j.jaad.2024.07.1531.Peer-Reviewed Original ResearchExtramammary Paget's diseaseSecondary extramammary Paget's diseaseVulvar extramammary Paget diseasePerianal extramammary Paget's diseaseUrine cytologyAnatomic subtypesComputed tomographyPaget's diseaseProstate-specific antigen testingHigh-risk featuresOrgan-specific testsMultidisciplinary expert panelUnderlying malignancySystematic follow-upFollow-upAdenocarcinomaAntigen testAnatomical locationInclusion criteriaCytologyRetrospective dataScreening testSubtypesScreening algorithmRecommendation statements
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply